Galway, September 2005. XXXXth Sir Peter Freyer Memorial Lecture and Surgical Symposium.

1.     A comparison of open (OR) and endovascular abdominal aortic aneurysm repair (EVAR) with best medical treatment (BMT). Has the availability of EVAR expanded our indications for intervention, and improved survival? (Plenary Session)

2.     Demographic changes in the level and numbers of amputees since the introduction of Subintimal Angioplasty (SIA). Influence of Deliberate Practice on Limb Salvage Rates and Long-term in Critical Lower Limb Ischaemia (CLI): A 15-years experience.

3.     A Prospective Observational Study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA) in High-Risk Patients. Short term results.

4.     A Biomechanical device for Non-operative management of Critical limb Ischemia (CLI): Initial short term experience.

5.     An Observational Parallel Group Comparison Study of Duplex Ultrasound Arterial Mapping (DUAM) with Magnetic Resonance Angiography (MRA) and Conventional Angiography (CA) as Sole Pre-operative Investigative Tools for Endovascular revascularizations

6.     Haemoglobin A1C (HbA1c) in nondiabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?

7.     A Prospective Observational Longitudinal Study of Pharmacological Manipulation in Abdominal Aortic Aneurysm (AAA) Surgery:  Are Statins, Beta-blockers and Anti-platelet Therapy the Best Combination?

8.     Video Presentation: Life of a Trainee Vascular Surgeon. E Ryan, P King J Diener, S Sultan.

Galway, 2005. Irish Angiology Society conference

9.     A Prospective Observational Study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA) in High-Risk Patients. Technical and Clinical Outcome.

10.   A Biomechanical device for Non-operative management of Critical limb Ischemia (CLI): Initial short term experience.

11.   Haemoglobin A1c (HbA1c) in nondiabetic vascular patients. is hba1c an independent risk factor and predictor of adverse outcome?.   

12.   Pharmacological Manipulation in Abdominal Aortic Aneurysm (AAA) Surgery: Are Statins, Beta-blockers and Anti-platelet Therapy the Best Combination? A Prospective Observational Longitudinal Study.

13.   A Double-Blinded Randomized Trial of Thin versus Ultra-thin Dacron Patching during Carotid Endarterectomy (CEA): Mid-term Results.

14.   Continuous Auto-Transfusion System (CATS) in Open AAA repair: A seven-year experience.

15.   A Prospective Comparative Analysis of Distaflo versus Gortex grafts in infrainguinal supragenicular vascular disease in critical limb ischaemia.

Limerick, March 2005 Sylvester O’Halloran Surgical Meeting,

16.   A prospective observational study of Carotid artery Stenting (CAST) under neuro-protection and carotid endarterectomy (CEA) in high risk patients. Technical and Clinical Outcome.

Dublin, 2005. RAMI Registrar's Prize Meeting 2005 (Surgical Section),

17.   A Comparison of EVAR & Open Repair with Best Medical Treatment. Has the availability of EVAR expanded our indications for intervention & improved Patient survival?

Bournemouth, UK. November 2005. Annual Meeting of the Vascular Society of Great Britain and Ireland

1.     The West Of Ireland Screening For Health (WISH) Pilot Scheme: Epidemiology And Health Gain From Rupture Abdominal Aortic Aneurysm (AAA), Stroke, Amputation and Death Using Fast ABCD (Aorta, Ankle/Brachial Pressure Index (ABI) and Carotid Duplex).

Palermo, Italy, October 2005: Jacobson Prize Session, 15th Congress of the Mediterranean League of Angiology and Vascular Surgery.

2.     Carotid Artery Stenting (CAST) vs. Carotid Endarterectomy (CEA) in High-risk Patients.

3.     Changes in the Management of Critical Lower Limb Ischaemia (CLI): hThe influence of deliberate Practice on Limb Salvage Rates and Long-Term survival: A 15-years Experience.

Helsinki, Finland, September 2005: The European Society for Vascular Surgery, XIX Annual Meeting, 

4.     Critical Bleeding in Vascular Surgery, Expanding the Indication of Recombinant Activated Factor VII (rFVIIa).

  1. A comparison of open (OR) and endovascular abdominal aortic aneurysm repair (EVAR) with best medical treatment (BMT). Has the availability of EVAR expanded our indications for intervention, and improved survival?

6.     Haemoglobin A1C (HbA1c) in nondiabetic vascular patients. Is hba1c an independent risk factor and predictor of adverse outcome?

Chicago, Illinois, USA, June 2005. Peripheral Vascular Surgical Society (PVSS),

  1. Haemoglobin A1C (HBA1c) in nondiabetic vascular patients is an independent risk factor and predictor of adverse outcome. A cohort study.

Cannes, France, June 2005. MEET congress Multi-disciplinary European Endovascular Therapy.

  1. Demographic changes in the level and numbers of amputees since the introduction of Subintimal Angioplasty (SIA). Influence of Deliberate Practice on Limb Salvage Rates and Long-term in Critical Lower Limb Ischaemia (CLI): A 15-years experience.
  2. Non-operative management of Critical limb Ischemia (CLI) using a Sequential Compression Device- Early experience & Lessons learned.
  3. An Observational Parallel Group Comparison Study of Duplex Ultrasound Arterial Mapping (DUAM) with Magnetic Resonance Angiography (MRA) and Conventional Angiography (CA) as Sole Pre-operative Investigative Tools for Endovascular revascularizations.

Coral Gables, Florida, March 2005.  Peter B. Samuels Award Competition, Society for Clinical Vascular Surgery, 33rd Annual Symposium on Vascular Surgery.

11.   Demographic changes in the level and numbers of amputees since the introduction of Subintimal Angioplasty. Influence on Limb Salvage Rates in Lower Limb Critical Ischaemia: A 15-years experience.

  1. A Prospective observational parallel group comparison study comparing Duplex Ultrasound Arterial Mapping (DUAM) as sole investigative tool for angioplasty with Magnetic Resonance Angiography (MRA) or Conventional Angiography (CA).

New York, USA, November 2005: ISVS Award Papers, VEITHsymposium, 32nd Annual Symposium on Vascular and Endovascular Issues

A Comparison Of Open And Endovascular Abdominal Aortic Aneurysm Repair With Best Medical Treatment: Has The Availability Of EVAR Expanded Our Indications For Intervention And Improved Survival?


Posters

XXXXth Sir Peter Freyer Memorial Lecture and Surgical Symposium, Galway, 2005

1.     Abdominal Aortic Aneurysm (AAA) repair in Octagenarians versus Younger patients in a tertiary referral centre. 5-year survival arte of non-operative AAA.

2.     Open AAA repair using Continuous Auto-Transfusion System (CATS): A Seven-year experience.

3.     Homocysteine levels, cardiovascular risk factors and complication rates in vascular surgery and endovascular surgery: is there a correlation?

4.     Materialise’s Interactive Medical Imaging Control System (MIMICS) and Finite Element Analysis (FEA) in predicting Abdominal Aortic Aneurysm (AAA) rupture - A prospective study in a tertiary referral centre.

5.     A Double-Blinded Randomized Trial of Thin versus Ultra-thin Dacron Patching during Carotid Endarterectomy (CEA): Mid-term Results.

6.     How to Pioneer a Vascular Biobank. An Initial Experience.

Glasgow, 2005. Association of Surgeons of Great Britain and Ireland, Annual Meeting,

7.     Short-term results of a prospective study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA) in high risk patients.

Galway, 2005. Irish Angiology Society conference.

8.     A Novel Model for Adventitial Gene Delivery to Balloon-Injured Rabbit Carotid Arteries.

9.     A comparison of open (OR) and endovascular abdominal aortic aneurysm repair (EVAR) with best medical treatment (BMT). Has the availability of EVAR expanded our indications for intervention, and improved survival?

Limerick, Ireland, March 2005, Sylvestor O’Halloran Surgical Meeting

10.   Initial short term experience in non-operative management of critical limb ischaemia (CLI) using a biomedical device.

Implementation of the continuous auto-transfusion system (CATS) in open AAA repair: a seven-year experience.